Neurological Disorders in Schizophrenia

Psychiatric Clinics of North America

Volumn 32, Issue 4, 2009, Pages 719-757

  Danielyan, Arman ^a   Nasrallah, Henry A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Antipsychotics; Cognitive; Gray matter; Neurological; Schizophrenia; White matter

Indexed keywords

AMISULPRIDE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; FLUPHENAZINE DECANOATE; HALOPERIDOL; NEUROLEPTIC AGENT; NICOTINE; OLANZAPINE; PLACEBO; QUETIAPINE; RISPERIDONE; SERTINDOLE; ZIPRASIDONE;

AGRANULOCYTOSIS; BRAIN MALFORMATION; BRAIN METABOLISM; BRAIN SIZE; CLINICAL TRIAL; COGNITIVE DEFECT; DRUG RESPONSE; DYSKINESIA; EEG ABNORMALITY; EPILEPSY; EYE MOVEMENT DISORDER; GENETIC ASSOCIATION; GRAY MATTER; HUMAN; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NOCICEPTION; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SYMPTOMATOLOGY; TARDIVE DYSKINESIA; WHITE MATTER;

ANTIPSYCHOTIC AGENTS; BRAIN; BRAIN DISEASES; COGNITION DISORDERS; ELECTROENCEPHALOGRAPHY; EPILEPSY; HUMANS; MOVEMENT DISORDERS; SCHIZOPHRENIA; SOMATOFORM DISORDERS;

EID: 70450284581     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2009.08.004     Document Type: Review

References (341)

1. Kasai K., Iwanami A., Yamasue H., et al. Neuroanatomy and neurophysiology in schizophrenia. Neurosci Res 43 2 (2002) 93-110
2. Nasrallah H.A., and Smeltzer D.J. Contemporary diagnosis and management of the patient with schizophrenia (2003), Handbooks in Health Care, Philadelphia(PA)
3. Kraepelin E. Dementia praecox and paraphrenia (1919), Livingstone, Edinburgh
4. Haslam J. Observations on madness and melancholy (1809), The Classics of psychiatry and behavioral science library, New York
5. Hecker E. Die Hebephrenie. Arch Pathol Anat Physiol Klin Med 52 (1871) 394-409
6. Southard E.E. On the topographical distribution of cortex lesions and anomalies in dementia praecox, with some account of their functional significance. Am J Insanity 71 (1915) 603-671
7. Nasrallah H.A. Neurologic comorbidities in schizophrenia. J Clin Psychiatry 66 Suppl 6 (2005) 34-46
8. Steen R.G., Mull C., McClure R., et al. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry 188 (2006) 510-518
9. Cadet J.L., Rickler K.C., and Weinberger D.R. The neurologic examination in schizophrenia. In: Nasrallah H.A., and Weinberger D.R. (Eds). Handbook of schizophrenia, vol.1: The neurology of schizophrenia (1986), Elsevier, Amsterdam 1-48
10. Heinrichs D.W., and Buchanan R.W. Significance and meaning of neurological signs in schizophrenia. Am J Psychiatry 145 1 (1988) 11-18
11. Shenton M.E., Dickey C.C., Frumin M., et al. A review of MRI findings in schizophrenia. Schizophr Res 49 1-2 (2001) 1-52
12. Arango C., Kirkpatrick B., and Buchanan R.W. Neurological signs and the heterogeneity of schizophrenia. Am J Psychiatry 157 4 (2000) 560-565
13. Buchanan R.W., and Heinrichs D.W. The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res 27 3 (1989) 335-350
14. Merriam A.E., Kay S.R., Opler L.A., et al. Neurological signs and the positive-negative dimension in schizophrenia. Biol Psychiatry 28 3 (1990) 181-192
15. Flashman L.A., Flaum M., Gupta S., et al. Soft signs and neuropsychological performance in schizophrenia. Am J Psychiatry 153 4 (1996) 526-532
16. Wong A.H., Voruganti L.N., Heslegrave R.J., et al. Neurocognitive deficits and neurological signs in schizophrenia. Schizophr Res 23 2 (1997) 139-146
17. King D.J., Wilson A., Cooper S.J., et al. The clinical correlates of neurological soft signs in chronic schizophrenia. Br J Psychiatry 158 (1991) 770-775
18. Mohr F., Hubmann W., Cohen R., et al. Neurological soft signs in schizophrenia: assessment and correlates. Eur Arch Psychiatry Clin Neurosci 246 5 (1996) 240-248
19. Manschreck T.C., Maher B.A., Rucklos M.E., et al. Disturbed voluntary motor activity in schizophrenic disorder. Psychol Med 12 1 (1982) 73-84
20. Rochford J.M., Detre T., Tucker G.J., et al. Neuropsychological impairments in functional psychiatric diseases. Arch Gen Psychiatry 22 2 (1970) 114-119
21. Breggin P.R. Does clozapine treatment cause brain disease?. Arch Gen Psychiatry 55 9 (1998) 845
22. Torrey E.F. Studies of individuals with schizophrenia never treated with antipsychotic medications: a review. Schizophr Res 58 2-3 (2002) 101-115
23. Gur R.E., Turetsky B.I., Bilker W.B., et al. Reduced gray matter volume in schizophrenia. Arch Gen Psychiatry 56 10 (1999) 905-911
24. Lieberman J., Bogerts B., Degreef G., et al. Qualitative assessment of brain morphology in acute and chronic schizophrenia. Am J Psychiatry 149 6 (1992) 784-794
25. Schulz S.C., Koller M.M., Kishore P.R., et al. Ventricular enlargement in teenage patients with schizophrenia spectrum disorder. Am J Psychiatry 140 12 (1983) 1592-1595
26. Keshavan M.S., Tandon R., Boutros N.N., et al. Schizophrenia, "just the facts": what we know in 2008 part 3: neurobiology. Schizophr Res 106 2-3 (2008) 89-107
27. Keshavan M.S., Prasad K.M., and Pearlson G. Are brain structural abnormalities useful as endophenotypes in schizophrenia?. Int Rev Psychiatry 19 4 (2007) 397-406
28. Prasad K.M., Sanders R., Sweeney J., et al. Neurological abnormalities among offspring of persons with schizophrenia: relation to premorbid psychopathology. Schizophr Res 108 1-3 (2009) 163-169
29. Meisenzahl E.M., Koutsouleris N., Bottlender R., et al. Structural brain alterations at different stages of schizophrenia: a voxel-based morphometric study. Schizophr Res 104 1-3 (2008) 44-60
30. Vita A., De Peri L., Silenzi C., et al. Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr Res 82 1 (2006) 75-88
31. Velakoulis D., Wood S.J., Wong M.T., et al. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiatry 63 2 (2006) 139-149
32. Lawrie S.M., and Abukmeil S.S. Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J Psychiatry 172 (1998) 110-120
33. Wright I.C., Rabe-Hesketh S., Woodruff P.W., et al. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 157 1 (2000) 16-25
34. McCarley R.W., Wible C.G., Frumin M., et al. MRI anatomy of schizophrenia. Biol Psychiatry 45 9 (1999) 1099-1119
35. Harrison P.J. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122 Pt 4 (1999) 593-624
36. Barkataki I., Kumari V., Das M., et al. Volumetric structural brain abnormalities in men with schizophrenia or antisocial personality disorder. Behav Brain Res 169 2 (2006) 239-247
37. Crespo-Facorro B., Barbadillo L., Pelayo-Teran J.M., et al. Neuropsychological functioning and brain structure in schizophrenia. Int Rev Psychiatry 19 4 (2007) 325-336
38. Cahn W., Hulshoff Pol H.E., Lems E.B., et al. Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Arch Gen Psychiatry 59 11 (2002) 1002-1010
39. Nasrallah H.A., Schwarzkopf S.B., Olson S.C., et al. Gender differences in schizophrenia on MRI brain scans. Schizophr Bull 16 2 (1990) 205-210
40. Wexler B.E., Zhu H., Bell M.D., et al. Neuropsychological near normality and brain structure abnormality in schizophrenia. Am J Psychiatry 166 2 (2009) 189-195
41. Ho B.C., Andreasen N.C., Nopoulos P., et al. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry 60 6 (2003) 585-594
42. Pagsberg A.K., Baare W.F., Raabjerg Christensen A.M., et al. Structural brain abnormalities in early onset first-episode psychosis. J Neural Transm 114 4 (2007) 489-498
43. McCreadie R.G., Thara R., Padmavati R., et al. Structural brain differences between never-treated patients with schizophrenia, with and without dyskinesia, and normal control subjects: a magnetic resonance imaging study. Arch Gen Psychiatry 59 4 (2002) 332-336
44. Begre S., and Koenig T. Cerebral disconnectivity: an early event in schizophrenia. Neuroscientist 14 1 (2008) 19-45
45. Zipparo L., Whitford T.J., Redoblado Hodge M.A., et al. Investigating the neuropsychological and neuroanatomical changes that occur over the first 2-3 years of illness in patients with first-episode schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 32 2 (2008) 531-538
46. Kubicki M., Park H., Westin C.F., et al. DTI and MTR abnormalities in schizophrenia: analysis of white matter integrity. Neuroimage 26 4 (2005) 1109-1118
47. Kubicki M., McCarley R.W., and Shenton M.E. Evidence for white matter abnormalities in schizophrenia. Curr Opin Psychiatry 18 2 (2005) 121-134
48. Thompson P.M., Vidal C., Giedd J.N., et al. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci U S A 98 20 (2001) 11650-11655
49. Gur R.E., Turetsky B.I., Cowell P.E., et al. Temporolimbic volume reductions in schizophrenia. Arch Gen Psychiatry 57 8 (2000) 769-775
50. Salgado-Pineda P., Baeza I., Perez-Gomez M., et al. Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naïve schizophrenic patients. Neuroimage 19 2 Pt 1 (2003) 365-375
51. Whitford T.J., Grieve S.M., Farrow T.F., et al. Progressive grey matter atrophy over the first 2-3 years of illness in first-episode schizophrenia: a tensor-based morphometry study. Neuroimage 32 2 (2006) 511-519
52. McCarley R.W., Salisbury D.F., Hirayasu Y., et al. Association between smaller left posterior superior temporal gyrus volume on magnetic resonance imaging and smaller left temporal P300 amplitude in first-episode schizophrenia. Arch Gen Psychiatry 59 4 (2002) 321-331
53. Hulshoff Pol H.E., Schnack H.G., Bertens M.G., et al. Volume changes in gray matter in patients with schizophrenia. Am J Psychiatry 159 2 (2002) 244-250
54. Molina V., Sanz J., Sarramea F., et al. Lower prefrontal gray matter volume in schizophrenia in chronic but not in first episode schizophrenia patients. Psychiatry Res 131 1 (2004) 45-56
55. Nakamura M., Salisbury D.F., Hirayasu Y., et al. Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study. Biol Psychiatry 62 7 (2007) 773-783
56. Farrow T.F., Whitford T.J., Williams L.M., et al. Diagnosis-related regional gray matter loss over two years in first episode schizophrenia and bipolar disorder. Biol Psychiatry 58 9 (2005) 713-723
57. van Haren N.E., Hulshoff Pol H.E., Schnack H.G., et al. Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study. Neuropsychopharmacology 32 10 (2007) 2057-2066
58. Saijo T., Abe T., Someya Y., et al. Ten year progressive ventricular enlargement in schizophrenia: an MRI morphometrical study. Psychiatry Clin Neurosci 55 1 (2001) 41-47
59. Chua S.E., Cheung C., Cheung V., et al. Cerebral grey, white matter and csf in never-medicated, first-episode schizophrenia. Schizophr Res 89 1-3 (2007) 12-21
60. Douaud G., Smith S., Jenkinson M., et al. Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. Brain 130 Pt 9 (2007) 2375-2386
61. Eack S.M., George M.M., Prasad K.M., et al. Neuroanatomical substrates of foresight in schizophrenia. Schizophr Res 103 1-3 (2008) 62-70
62. Weiss A.P., Zalesak M., DeWitt I., et al. Impaired hippocampal function during the detection of novel words in schizophrenia. Biol Psychiatry 55 7 (2004) 668-675
63. Nugent III T.F., Herman D.H., Ordonez A., et al. Dynamic mapping of hippocampal development in childhood onset schizophrenia. Schizophr Res 90 1-3 (2007) 62-70
64. Thoma R.J., Monnig M., Hanlon F.M., et al. Hippocampus volume and episodic memory in schizophrenia. J Int Neuropsychol Soc 15 2 (2009) 182-195
65. Shimizu M., Fujiwara H., Hirao K., et al. Structural abnormalities of the adhesio interthalamica and mediodorsal nuclei of the thalamus in schizophrenia. Schizophr Res 101 1-3 (2008) 331-338
66. Gur R.E., Maany V., Mozley P.D., et al. Subcortical MRI volumes in neuroleptic-naïve and treated patients with schizophrenia. Am J Psychiatry 155 12 (1998) 1711-1717
67. Gilbert A.R., Rosenberg D.R., Harenski K., et al. Thalamic volumes in patients with first-episode schizophrenia. Am J Psychiatry 158 4 (2001) 618-624
68. Ettinger U., Chitnis X.A., Kumari V., et al. Magnetic resonance imaging of the thalamus in first-episode psychosis. Am J Psychiatry 158 1 (2001) 116-118
69. Seidman L.J., Faraone S.V., Goldstein J.M., et al. Thalamic and amygdala-hippocampal volume reductions in first-degree relatives of patients with schizophrenia: an MRI-based morphometric analysis. Biol Psychiatry 46 7 (1999) 941-954
70. Lui S., Deng W., Huang X., et al. Neuroanatomical differences between familial and sporadic schizophrenia and their parents: an optimized voxel-based morphometry study. Psychiatry Res 171 2 (2009) 71-81
71. Keshavan M.S., Rosenberg D., Sweeney J.A., et al. Decreased caudate volume in neuroleptic-naïve psychotic patients. Am J Psychiatry 155 6 (1998) 774-778
72. Shihabuddin L., Buchsbaum M.S., Hazlett E.A., et al. Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task. Arch Gen Psychiatry 55 3 (1998) 235-243
73. Corson P.W., Nopoulos P., Andreasen N.C., et al. Caudate size in first-episode neuroleptic-naïve schizophrenic patients measured using an artificial neural network. Biol Psychiatry 46 5 (1999) 712-720
74. Karlsson P., Farde L., Halldin C., et al. PET study of D(1) dopamine receptor binding in neuroleptic-naïve patients with schizophrenia. Am J Psychiatry 159 5 (2002) 761-767
75. Keshavan M.S., Haas G.L., Kahn C.E., et al. Superior temporal gyrus and the course of early schizophrenia: progressive, static, or reversible?. J Psychiatr Res 32 3-4 (1998) 161-167
76. Kasparek T., Prikryl R., Schwarz D., et al. Movement sequencing abilities and basal ganglia morphology in first-episode schizophrenia. World J Biol Psychiatry 30 (2008) 1-11 [Epub ahead of print]
77. McDonald B., Highley J.R., Walker M.A., et al. Anomalous asymmetry of fusiform and parahippocampal gyrus gray matter in schizophrenia: a postmortem study. Am J Psychiatry 157 1 (2000) 40-47
78. White T., Andreasen N.C., Nopoulos P., et al. Gyrification abnormalities in childhood- and adolescent-onset schizophrenia. Biol Psychiatry 54 4 (2003) 418-426
79. Vogeley K., Schneider-Axmann T., Pfeiffer U., et al. Disturbed gyrification of the prefrontal region in male schizophrenic patients: a morphometric postmortem study. Am J Psychiatry 157 1 (2000) 34-39
80. Joyal C.C., Laakso M.P., Tiihonen J., et al. A volumetric MRI study of the entorhinal cortex in first episode neuroleptic-naïve schizophrenia. Biol Psychiatry 51 12 (2002) 1005-1007
81. Degreef G., Lantos G., Bogerts B., et al. Abnormalities of the septum pellucidum on MR scans in first-episode schizophrenic patients. AJNR Am J Neuroradiol 13 3 (1992) 835-840
82. Keshavan M.S., Jayakumar P.N., Diwadkar V.A., et al. Cavum septi pellucidi in first-episode patients and young relatives at risk for schizophrenia. CNS Spectr 7 2 (2002) 155-158
83. Begre S., Kleinlogel H., Kiefer C., et al. White matter anisotropy related to electrophysiology of first episode schizophrenia during NoGo inhibition. Neurobiol Dis 30 2 (2008) 270-280
84. Burns J.K. An evolutionary theory of schizophrenia: cortical connectivity, metarepresentation, and the social brain. Behav Brain Sci 27 6 (2004) 831-855 [discussion: 855-85]
85. Crow T.J., Paez P., and Chance S.A. Callosal misconnectivity and the sex difference in psychosis. Int Rev Psychiatry 19 4 (2007) 449-457
86. Friston K.J., and Frith C.D. Schizophrenia: a disconnection syndrome?. Clin Neurosci 3 2 (1995) 89-97
87. Konrad A., Vucurevic G., Musso F., et al. ErbB4 genotype predicts left frontotemporal structural connectivity in human brain. Neuropsychopharmacology 34 3 (2009) 641-650
88. Spoletini I., Cherubini A., Di Paola M., et al. Reduced fronto-temporal connectivity is associated with frontal gray matter density reduction and neuropsychological deficit in schizophrenia. Schizophr Res 108 1-3 (2009) 57-68
89. Karlsgodt K.H., Sun D., Jimenez A.M., et al. Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia. Dev Psychopathol 20 4 (2008) 1297-1327
90. Koch G., Ribolsi M., Mori F., et al. Connectivity between posterior parietal cortex and ipsilateral motor cortex is altered in schizophrenia. Biol Psychiatry 64 9 (2008) 815-819
91. Konrad A., and Winterer G. Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon?. Schizophr Bull 34 1 (2008) 72-92
92. Kubicki M., Styner M., Bouix S., et al. Reduced interhemispheric connectivity in schizophrenia-tractography based segmentation of the corpus callosum. Schizophr Res 106 2-3 (2008) 125-131
93. Magnotta V.A., Adix M.L., Caprahan A., et al. Investigating connectivity between the cerebellum and thalamus in schizophrenia using diffusion tensor tractography: a pilot study. Psychiatry Res 163 3 (2008) 193-200
94. Welsh R.C., Chen A.C., and Taylor S.F. Low-frequency BOLD fluctuations demonstrate altered thalamocortical connectivity in schizophrenia. Schizophr Bull (2008) [Epub ahead of print]
95. Williams L.M. Voxel-based morphometry in schizophrenia: implications for neurodevelopmental connectivity models, cognition and affect. Expert Rev Neurother 8 7 (2008) 1049-1065
96. Kubicki M., Westin C.F., McCarley R.W., et al. The application of DTI to investigate white matter abnormalities in schizophrenia. Ann N Y Acad Sci 1064 (2005) 134-148
97. Wernicke K. Grundriss Der Psychiatrie Leipzig (1906), Verlag von Georg Thieme
98. Bleuler E. Dementia Praecox, Oder Gruppe Der Schizophrenien (1911), F. Deuticke, Leipzig
99. Kyriakopoulos M., Vyas N.S., Barker G.J., et al. A diffusion tensor imaging study of white matter in early-onset schizophrenia. Biol Psychiatry 63 5 (2008) 519-523
100. Witthaus H., Brune M., Kaufmann C., et al. White matter abnormalities in subjects at ultra high-risk for schizophrenia and first-episode schizophrenic patients. Schizophr Res 102 1-3 (2008) 141-149
101. Szeszko P.R., Ardekani B.A., Ashtari M., et al. White matter abnormalities in first-episode schizophrenia or schizoaffective disorder: a diffusion tensor imaging study. Am J Psychiatry 162 3 (2005) 602-605
102. Kumra S., Ashtari M., Cervellione K.L., et al. White matter abnormalities in early-onset schizophrenia: a voxel-based diffusion tensor imaging study. J Am Acad Child Adolesc Psychiatry 44 9 (2005) 934-941
103. Hao Y., Liu Z., Jiang T., et al. White matter integrity of the whole brain is disrupted in first-episode schizophrenia. Neuroreport 17 1 (2006) 23-26
104. Mori T., Ohnishi T., Hashimoto R., et al. Progressive changes of white matter integrity in schizophrenia revealed by diffusion tensor imaging. Psychiatry Res 154 2 (2007) 133-145
105. Federspiel A., Begre S., Kiefer C., et al. Alterations of white matter connectivity in first episode schizophrenia. Neurobiol Dis 22 3 (2006) 702-709
106. Fields R.D. White matter in learning, cognition and psychiatric disorders. Trends Neurosci 31 7 (2008) 361-370
107. Bartzokis G., Lu P.H., Nuechterlein K.H., et al. Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia. Schizophr Res 93 1-3 (2007) 13-22
108. Davis K.L., Stewart D.G., Friedman J.I., et al. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry 60 5 (2003) 443-456
109. Gazzaniga M.S. Cerebral specialization and interhemispheric communication: does the corpus callosum enable the human condition?. Brain 123 Pt 7 (2000) 1293-1326
110. Bloom J.S., and Hynd G.W. The role of the corpus callosum in interhemispheric transfer of information: excitation or inhibition?. Neuropsychol Rev 15 2 (2005) 59-71
111. Downhill Jr. J.E., Buchsbaum M.S., Wei T., et al. Shape and size of the corpus callosum in schizophrenia and schizotypal personality disorder. Schizophr Res 42 3 (2000) 193-208
112. Tibbo P., Nopoulos P., Arndt S., et al. Corpus callosum shape and size in male patients with schizophrenia. Biol Psychiatry 44 6 (1998) 405-412
113. Venkatasubramanian G., Jayakumar P.N., Gangadhar B.N., et al. Measuring the corpus callosum in schizophrenia: a technique with neuroanatomical and cytoarchtectural basis. Neurol India 51 2 (2003) 189-192
114. Gasparotti R., Valsecchi P., Carletti F., et al. Reduced fractional anisotropy of corpus callosum in first-contact, antipsychotic drug-naïve patients with schizophrenia. Schizophr Res 108 1-3 (2009) 41-48
115. Harrison P.J. The neuropathological effects of antipsychotic drugs. Schizophr Res 40 2 (1999) 87-99
116. Girgis R.R., Diwadkar V.A., Nutche J.J., et al. Risperidone in first-episode psychosis: a longitudinal, exploratory voxel-based morphometric study. Schizophr Res 82 1 (2006) 89-94
117. Dazzan P., Morgan K.D., Orr K., et al. Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology 30 4 (2005) 765-774
118. Pariante C.M., Dazzan P., Danese A., et al. Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology 30 10 (2005) 1923-1931
119. Lieberman J.A., Stroup T.S., McEvoy J.P., et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353 12 (2005) 1209-1223
120. Koning J.P., Tenback D.E., van Os J., et al. Dyskinesia and parkinsonism in antipsychotic-naïve patients with schizophrenia, first-degree relatives and healthy controls: a meta-analysis. Schizophr Bull (2008) [Epub ahead of print]
121. Mittal V.A., Neumann C., Saczawa M., et al. Longitudinal progression of movement abnormalities in relation to psychotic symptoms in adolescents at high risk of schizophrenia. Arch Gen Psychiatry 65 2 (2008) 165-171
122. Hoy K.E., Georgiou-Karistianis N., Farrow M., et al. Neurological soft signs in schizophrenia: investigating motor overflow. World J Biol Psychiatry 1 (2008) 1-9 [Epub ahead of print]
123. Casey D.E., and Hansen T.E. Spontaneous dyskinesias. In: Jeste D.V., and Wyatt R.J. (Eds). Neuropsychiatric movement disorders (1984), American Psychiatric Press, Washington, DC 68-95
124. Gerlach J., and Casey D.E. Tardive dyskinesia. Acta Psychiatr Scand 77 4 (1988) 369-378
125. Llorca P.M., Chereau I., Bayle F.J., et al. Tardive dyskinesias and antipsychotics: a review. Eur Psychiatry 17 3 (2002) 129-138
126. Fenton W.S. Prevalence of spontaneous dyskinesia in schizophrenia. J Clin Psychiatry 61 Suppl 4 (2000) 10-14
127. Turner T.H. Schizophrenia and mental handicap: an historical review, with implications for further research. Psychol Med 19 2 (1989) 301-314
128. Reiter P.J. Extrapyramidal motor-disturbances in dementia praecox. Acta Psychiatr Neurol Scand 1 (1926) 287-309
129. Farran-Ridge C. Some symptoms referable to the basal ganglia occurring in dementia praecox and epidemic encephalitis. J Ment Sci 72 (1926) 513-523
130. Kane J.M., and Smith J.M. Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. Arch Gen Psychiatry 39 4 (1982) 473-481
131. Chatterjee A., Chakos M., Koreen A., et al. Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients. Am J Psychiatry 152 12 (1995) 1724-1729
132. Gervin M., Browne S., Lane A., et al. Spontaneous abnormal involuntary movements in first-episode schizophrenia and schizophreniform disorder: baseline rate in a group of patients from an Irish catchment area. Am J Psychiatry 155 9 (1998) 1202-1206
133. Puri B.K., Barnes T.R., Chapman M.J., et al. Spontaneous dyskinesia in first episode schizophrenia. J Neurol Neurosurg Psychiatr 66 1 (1999) 76-78
134. McCreadie R.G., Thara R., Kamath S., et al. Abnormal movements in never-medicated Indian patients with schizophrenia. Br J Psychiatry 168 2 (1996) 221-226
135. Fenton W.S., Blyler C.R., Wyatt R.J., et al. Prevalence of spontaneous dyskinesia in schizophrenic and non-schizophrenic psychiatric patients. Br J Psychiatry 171 (1997) 265-268
136. Bai Y.M., Chou K.H., Lin C.P., et al. White matter abnormalities in schizophrenia patients with tardive dyskinesia: a diffusion tensor image study. Schizophr Res 109 1-3 (2009) 167-181
137. Zai C.C., Tiwari A.K., Basile V., et al. Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patients. Pharmacogenomics J 9 3 (2009) 168-174
138. Tenback D.E., van Harten P.N., Slooff C.J., et al. Evidence that early extrapyramidal symptoms predict later tardive dyskinesia: a prospective analysis of 10,000 patients in the European Schizophrenia Outpatient Health Outcomes (SOHO) study. Am J Psychiatry 163 8 (2006) 1438-1440
139. Emsley R., Turner H.J., Schronen J., et al. A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia. J Clin Psychiatry 65 5 (2004) 696-701
140. Kopala L.C., Good K.P., Milliken H., et al. Treatment of a first episode of psychotic illness with quetiapine: an analysis of 2 year outcomes. Schizophr Res 81 1 (2006) 29-39
141. Morgante L., Epifanio A., Spina E., et al. Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis. Clin Neuropharmacol 27 4 (2004) 153-156
142. Morgante L., Epifanio A., Spina E., et al. Quetiapine versus clozapine: a preliminary report of comparative effects on dopaminergic psychosis in patients with Parkinson's disease. Neurol Sci 23 Suppl 2 (2002) S89-S90
143. Manson A.J., Schrag A., and Lees A.J. Low-dose olanzapine for levodopa induced dyskinesias. Neurology 55 6 (2000) 795-799
144. Carlson C.D., Cavazzoni P.A., Berg P.H., et al. An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine. J Clin Psychiatry 64 8 (2003) 898-906
145. Schooler N., Rabinowitz J., Davidson M., et al. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. Am J Psychiatry 162 5 (2005) 947-953
146. Trimble M.R. The neurology of schizophrenia. Br Med Bull 43 3 (1987) 587-598
147. Mittal V.A., Hasenkamp W., Sanfilipo M., et al. Relation of neurological soft signs to psychiatric symptoms in schizophrenia. Schizophr Res 94 1-3 (2007) 37-44
148. Browne S., Clarke M., Gervin M., et al. Determinants of neurological dysfunction in first episode schizophrenia. Psychol Med 30 6 (2000) 1433-1441
149. Schroder J., Niethammer R., Geider F.J., et al. Neurological soft signs in schizophrenia. Schizophr Res 6 1 (1991) 25-30
150. Madsen A.L., Vorstrup S., Rubin P., et al. Neurological abnormalities in schizophrenic patients: a prospective follow-up study 5 years after first admission. Acta Psychiatr Scand 100 2 (1999) 119-125
151. Thomann P.A., Wustenberg T., Santos V.D., et al. Neurological soft signs and brain morphology in first-episode schizophrenia. Psychol Med 39 3 (2009) 371-379
152. Dazzan P., and Murray R.M. Neurological soft signs in first-episode psychosis: a systematic review. Br J Psychiatry Suppl 43 (2002) s50-s57
153. Keshavan M.S., Sanders R.D., Sweeney J.A., et al. Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses. Am J Psychiatry 160 7 (2003) 1298-1304
154. Kolakowska T., Williams A.O., Jambor K., et al. Schizophrenia with good and poor outcome. III: neurological 'soft' signs, cognitive impairment and their clinical significance. Br J Psychiatry 146 (1985) 348-357
155. Krebs M.O., and Mouchet S. Neurological soft signs and schizophrenia: a review of current knowledge. Rev Neurol (Paris) 163 12 (2007) 1157-1168
156. Biswas P., Malhotra S., Malhotra A., et al. Comparative study of neurological soft signs in schizophrenia with onset in childhood, adolescence and adulthood. Acta Psychiatr Scand 115 4 (2007) 295-303
157. Prikryl R., Ceskova E., Kasparek T., et al. Neurological soft signs and their relationship to 1-year outcome in first-episode schizophrenia. Eur Psychiatry 22 8 (2007) 499-504
158. Manschreck T.C., and Ames D. Neurologic features and psychopathology in schizophrenic disorders. Biol Psychiatry 19 5 (1984) 703-719
159. Bottmer C., Bachmann S., Pantel J., et al. Reduced cerebellar volume and neurological soft signs in first-episode schizophrenia. Psychiatry Res 140 3 (2005) 239-250
160. Holzman P.S., Solomon C.M., Levin S., et al. Pursuit eye movement dysfunctions in schizophrenia. Family evidence for specificity. Arch Gen Psychiatry 41 2 (1984) 136-139
161. Bachmann S., Bottmer C., and Schroder J. Neurological soft signs in first-episode schizophrenia: a follow-up study. Am J Psychiatry 162 12 (2005) 2337-2343
162. Lawrie S.M., Byrne M., Miller P., et al. Neurodevelopmental indices and the development of psychotic symptoms in subjects at high risk of schizophrenia. Br J Psychiatry 178 (2001) 524-530
163. Ismail B., Cantor-Graae E., and McNeil T.F. Minor physical anomalies in schizophrenic patients and their siblings. Am J Psychiatry 155 12 (1998) 1695-1702
164. Niethammer R., Weisbrod M., Schiesser S., et al. Genetic influence on laterality in schizophrenia? A twin study of neurological soft signs. Am J Psychiatry 157 2 (2000) 272-274
165. Prasad K.M., Sanders R., Sweeney J., et al. Neurological abnormalities among offspring of persons with schizophrenia: Relation to premorbid psychopathology. Schizophr Res 108 1-3 (2009) 163-169
166. Chan R.C., and Gottesman I.I. Neurological soft signs as candidate endophenotypes for schizophrenia: a shooting star or a Northern star?. Neurosci Biobehav Rev 32 5 (2008) 957-971
167. Schroder J., Essig M., Baudendistel K., et al. Motor dysfunction and sensorimotor cortex activation changes in schizophrenia: a study with functional magnetic resonance imaging. Neuroimage 9 1 (1999) 81-87
168. Andreasen N.C., O'Leary D.S., Cizadlo T., et al. Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. Proc Natl Acad Sci U S A 93 18 (1996) 9985-9990
169. Boks M.P., Liddle P.F., Burgerhof J.G., et al. Neurological soft signs discriminating mood disorders from first episode schizophrenia. Acta Psychiatr Scand 110 1 (2004) 29-35
170. Kinney D.K., Yurgelun-Todd D.A., and Woods B.T. Hard neurologic signs and psychopathology in relatives of schizophrenic patients. Psychiatry Res 39 1 (1991) 45-53
171. Griffiths T.D., Sigmundsson T., Takei N., et al. Neurological abnormalities in familial and sporadic schizophrenia. Brain 121 Pt 2 (1998) 191-203
172. Torrey E.F. Neurological abnormalities in schizophrenic patients. Biol Psychiatry 15 3 (1980) 381-388
173. Schroder J., Buchsbaum M.S., Siegel B.V., et al. Structural and functional correlates of subsyndromes in chronic schizophrenia. Psychopathology 28 1 (1995) 38-45
174. Nasrallah H.A., Tippin J., McCalley-Whitters M., et al. Neurological differences between paranoid and nonparanoid schizophrenia: part III. neurological soft signs. J Clin Psychiatry 43 8 (1982) 310-312
175. Gureje O. Neurological soft signs in Nigerian schizophrenics: a controlled study. Acta Psychiatr Scand 78 4 (1988) 505-509
176. Nasrallah H., Lyskowski J., and Shroeder D. Tricyclic-induced mania: differences between switchers and non-switchers. Biol Psychiatry 17 (1982) 271-274
177. Schroder J., Geider F.J., Binkert M., et al. Subsyndromes in chronic schizophrenia: do their psychopathological characteristics correspond to cerebral alterations?. Psychiatry Res 42 3 (1992) 209-220
178. Schroder J., Buchsbaum M.S., Siegel B.V., et al. Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia. Schizophr Res 19 1 (1996) 41-53
179. 123I-iodobenzamide single photon emission computed tomography in the drug-naïve state and after neuroleptic treatment. Biol Psychiatry 43 9 (1998) 660-665
180. Stevens J.R. An anatomy of schizophrenia?. Arch Gen Psychiatry 29 2 (1973) 177-189
181. Slaghuis W.L., Hawkes A., Holthouse T., et al. Eye movement and visual motion perception in schizophrenia I: apparent motion evoked smooth pursuit eye movement reveals a hidden dysfunction in smooth pursuit eye movement in schizophrenia. Exp Brain Res 182 3 (2007) 399-413
182. Slaghuis W.L., Holthouse T., Hawkes A., et al. Eye movement and visual motion perception in schizophrenia II: global coherent motion as a function of target velocity and stimulus density. Exp Brain Res 182 3 (2007) 415-426
183. Kallimani D., Theleritis C., Evdokimidis I., et al. The effect of change in clinical state on eye movement dysfunction in schizophrenia. Eur Psychiatry 24 1 (2009) 17-26
184. Suzuki M., Takahashi S., Matsushima E., et al. Exploratory eye movement dysfunction as a discriminator for schizophrenia: a large sample study using a newly developed digital computerized system. Eur Arch Psychiatry Clin Neurosci 259 3 (2009) 186-194
185. Takahashi S., Tanabe E., Yara K., et al. Impairment of exploratory eye movement in schizophrenia patients and their siblings. Psychiatry Clin Neurosci 62 5 (2008) 487-493
186. Takahashi S., Tanabe E., Sakai T., et al. Relationship between exploratory eye movement, P300, and reaction time in schizophrenia. Psychiatry Clin Neurosci 62 4 (2008) 396-403
187. Calkins M.E., Iacono W.G., and Ones D.S. Eye movement dysfunction in first-degree relatives of patients with schizophrenia: a meta-analytic evaluation of candidate endophenotypes. Brain Cogn 68 3 (2008) 436-461
188. Barch D.M., Carter C.S., Braver T.S., et al. Selective deficits in prefrontal cortex function in medication-naïve patients with schizophrenia. Arch Gen Psychiatry 58 3 (2001) 280-288
189. Egan M.F., Goldberg T.E., Kolachana B.S., et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98 12 (2001) 6917-6922
190. Goldberg T.E., Egan M.F., Gscheidle T., et al. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch Gen Psychiatry 60 9 (2003) 889-896
191. Perlstein W.M., Carter C.S., Noll D.C., et al. Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. Am J Psychiatry 158 7 (2001) 1105-1113
192. Quintana J., Wong T., Ortiz-Portillo E., et al. Prefrontal-posterior parietal networks in schizophrenia: primary dysfunctions and secondary compensations. Biol Psychiatry 53 1 (2003) 12-24
193. Weinberger D.R., Egan M.F., Bertolino A., et al. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 50 11 (2001) 825-844
194. Potkin S.G., Alva G., Fleming K., et al. A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography. Am J Psychiatry 159 2 (2002) 227-237
195. Pennington K., Beasley C.L., Dicker P., et al. Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder. Mol Psychiatry 13 12 (2008) 1102-1117
196. Smesny S., Rosburg T., Nenadic I., et al. Metabolic mapping using 2D 31P-MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophrenia. Neuroimage 35 2 (2007) 729-737
197. Glahn D.C., Ragland J.D., Abramoff A., et al. Beyond hypofrontality: a quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia. Hum Brain Mapp 25 1 (2005) 60-69
198. Schirmer T.N., Dorflinger J.M., Marlow-O'Connor M., et al. FMRI indices of auditory attention in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 33 1 (2009) 25-32
199. Hyde T.M., and Weinberger D.R. Seizures and schizophrenia. Schizophr Bull 23 4 (1997) 611-622
200. Marsh L., and Rao V. Psychiatric complications in patients with epilepsy: a review. Epilepsy Res 49 1 (2002) 11-33
201. Adachi N., Onuma T., Nishiwaki S., et al. Inter-ictal and post-ictal psychoses in frontal lobe epilepsy: a retrospective comparison with psychoses in temporal lobe epilepsy. Seizure 9 5 (2000) 328-335
202. Makikyro T., Karvonen J.T., Hakko H., et al. Comorbidity of hospital-treated psychiatric and physical disorders with special reference to schizophrenia: a 28 year follow-up of the 1966 northern Finland general population birth cohort. Public Health 112 4 (1998) 221-228
203. Cascella N.G., Schretlen D.J., and Sawa A. Schizophrenia and epilepsy: is there a shared susceptibility?. Neurosci Res 63 4 (2009) 227-235
204. Qin P., Xu H., Laursen T.M., et al. Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy: population based cohort study. BMJ 331 7507 (2005) 23
205. Manchanda R., Freeland A., Schaefer B., et al. Auras, seizure focus, and psychiatric disorders. Neuropsychiatry Neuropsychol Behav Neurol 13 1 (2000) 13-19
206. Adachi N., Hara T., Oana Y., et al. Difference in age of onset of psychosis between epilepsy and schizophrenia. Epilepsy Res 78 2-3 (2008) 201-206
207. Tebartz Van Elst L., Baeumer D., Lemieux L., et al. Amygdala pathology in psychosis of epilepsy: a magnetic resonance imaging study in patients with temporal lobe epilepsy. Brain 125 Pt 1 (2002) 140-149
208. Heath R.G. Common characteristics of epilepsy and schizophrenia: clinical observation and depth electrode studies. 1961. Epilepsy Behav 6 4 (2005) 633-645
209. Petersen M.C., Bickford G., Sem-Jacobsen C.W., et al. The depth electrogram in schizophrenic patients. Proc Staff Meet Mayo Clin 28 6 (1953) 170-175
210. Bob P., Palus M., Susta M., et al. EEG phase synchronization in patients with paranoid schizophrenia. Neurosci Lett 447 1 (2008) 73-77
211. Lauer C.J., and Krieg J.C. Slow-wave sleep and ventricular size: a comparative study in schizophrenia and major depression. Biol Psychiatry 44 2 (1998) 121-128
212. Lauer C.J., Schreiber W., Pollmacher T., et al. Sleep in schizophrenia: a polysomnographic study on drug-naïve patients. Neuropsychopharmacology 16 1 (1997) 51-60
213. Yang C., and Winkelman J.W. Clinical significance of sleep EEG abnormalities in chronic schizophrenia. Schizophr Res 82 2-3 (2006) 251-260
214. Higashima M., Takeda T., Kikuchi M., et al. State-dependent changes in intrahemispheric EEG coherence for patients with acute exacerbation of schizophrenia. Psychiatry Res 149 1-3 (2007) 41-47
215. Begre S., Federspiel A., Kiefer C., et al. Reduced hippocampal anisotropy related to anteriorization of alpha EEG in schizophrenia. Neuroreport 14 5 (2003) 739-742
216. Lehmann D., Faber P.L., Galderisi S., et al. EEG microstate duration and syntax in acute, medication-naïve, first-episode schizophrenia: a multi-center study. Psychiatry Res 138 2 (2005) 141-156
217. Koenig T., Lehmann D., Merlo M.C., et al. A deviant EEG brain microstate in acute, neuroleptic-naïve schizophrenics at rest. Eur Arch Psychiatry Clin Neurosci 249 4 (1999) 205-211
218. Boutros N.N., Arfken C., Galderisi S., et al. The status of spectral EEG abnormality as a diagnostic test for schizophrenia. Schizophr Res 99 1-3 (2008) 225-237
219. Koenig T., Lehmann D., Saito N., et al. Decreased functional connectivity of EEG theta-frequency activity in first-episode, neuroleptic-naïve patients with schizophrenia: preliminary results. Schizophr Res 50 1-2 (2001) 55-60
220. Boutros N.N., Torello M.W., Barker B.A., et al. The P50 evoked potential component and mismatch detection in normal volunteers: implications for the study of sensory gating. Psychiatry Res 57 1 (1995) 83-88
221. Patterson J.V., Hetrick W.P., Boutros N.N., et al. P50 sensory gating ratios in schizophrenics and controls: a review and data analysis. Psychiatry Res 158 2 (2008) 226-247
222. Kawasaki Y., Sumiyoshi T., Higuchi Y., et al. Voxel-based analysis of P300 electrophysiological topography associated with positive and negative symptoms of schizophrenia. Schizophr Res 94 1-3 (2007) 164-171
223. Ozgurdal S., Gudlowski Y., Witthaus H., et al. Reduction of auditory event-related P300 amplitude in subjects with at-risk mental state for schizophrenia. Schizophr Res 105 1-3 (2008) 272-278
224. Gonul A.S., Suer C., Coburn K., et al. Effects of olanzapine on auditory P300 in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 27 1 (2003) 173-177
225. Turetsky B.I., Moberg P.J., Mozley L.H., et al. Memory-delineated subtypes of schizophrenia: relationship to clinical, neuroanatomical, and neurophysiological measures. Neuropsychology 16 4 (2002) 481-490
226. Boutros N., Nasrallah H., Leighty R., et al. Auditory evoked potentials, clinical vs. research applications. Psychiatry Res 69 2-3 (1997) 183-195
227. Jeon Y.W., and Polich J. P300 asymmetry in schizophrenia: a meta-analysis. Psychiatry Res 104 1 (2001) 61-74
228. de Wilde O.M., Bour L.J., Dingemans P.M., et al. P300 deficits are present in young first-episode patients with schizophrenia and not in their healthy young siblings. Clin Neurophysiol 119 12 (2008) 2721-2726
229. Shin K.S., Kang D.H., Choi J.S., et al. Neuropsychological correlates of N400 anomalies in patients with schizophrenia: a preliminary report. Neurosci Lett 448 2 (2008) 226-230
230. Potvin S., Stip E., Tempier A., et al. Pain perception in schizophrenia: no changes in diffuse noxious inhibitory controls (DNIC) but a lack of pain sensitization. J Psychiatr Res 42 12 (2008) 1010-1016
231. Singh M.K., Giles L.L., and Nasrallah H.A. Pain insensitivity in schizophrenia: trait or state marker?. J Psychiatr Pract 12 2 (2006) 90-102
232. Fishbain D.A. Pain insensitivity in psychosis. Ann Emerg Med 11 11 (1982) 630-632
233. Guieu R., Samuelian J.C., and Coulouvrat H. Objective evaluation of pain perception in patients with schizophrenia. Br J Psychiatry 164 2 (1994) 253-255
234. Bender L., and Schilder P. Unconditioned and conditioned reactions to pain in schizophrenia. Am J Psychiatry 10 (1930) 365-384
235. Haslam J. Observations on insanity: with practical remarks on the disease (1798), F. and C. Rivington, London
236. Esquirol J.E. Des maladies mentales (1838), Bailliere, Paris
237. Lieberman A.L. Painless myocardial infarction in psychotic patients. Geriatrics 10 12 (1955) 579-580
238. Marchand W.E. Occurrence of painless myocardial infarction in psychotic patients. N Engl J Med 253 2 (1955) 51-55
239. Marchand W.E., Sarota B., Marble H.C., et al. Occurrence of painless acute surgical disorders in psychotic patients. N Engl J Med 260 12 (1959) 580-585
240. Tyler M. Somatic symptoms in schizophrenia. Schizophr Res 18 1 (1995) 87-88
241. Dworkin R.H. Pain insensitivity in schizophrenia: a neglected phenomenon and some implications. Schizophr Bull 20 2 (1994) 235-248
242. Bonnot O., and Tordjman S. Schizophrenia and pain reactivity. Presse Med 37 11 (2008) 1561-1568
243. Jochum T., Letzsch A., Greiner W., et al. Influence of antipsychotic medication on pain perception in schizophrenia. Psychiatry Res 142 2-3 (2006) 151-156
244. Mohamed S., Rosenheck R., Swartz M., et al. Relationship of cognition and psychopathology to functional impairment in schizophrenia. Am J Psychiatry 165 8 (2008) 978-987
245. Reichenberg A., Harvey P.D., Bowie C.R., et al. Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophr Bull 35 5 (2008) 1022-1029
246. Keefe R.S., and Fenton W.S. How should DSM-V criteria for schizophrenia include cognitive impairment?. Schizophr Bull 33 4 (2007) 912-920
247. Heinrichs R.W., Ammari N., Miles A., et al. Psychopathology and cognition in divergent functional outcomes in schizophrenia. Schizophr Res 109 1-3 (2009) 46-51
248. Frangou S., Hadjulis M., and Vourdas A. The Maudsley early onset schizophrenia study: cognitive function over a 4-year follow-up period. Schizophr Bull 34 1 (2008) 52-59
249. Waddington J.L., and Youssef H.A. Cognitive dysfunction in chronic schizophrenia followed prospectively over 10 years and its longitudinal relationship to the emergence of tardive dyskinesia. Psychol Med 26 4 (1996) 681-688
250. Szoke A., Trandafir A., Dupont M.E., et al. Longitudinal studies of cognition in schizophrenia: meta-analysis. Br J Psychiatry 192 4 (2008) 248-257
251. Riley E.M., McGovern D., Mockler D., et al. Neuropsychological functioning in first-episode psychosis-evidence of specific deficits. Schizophr Res 43 1 (2000) 47-55
252. Reichenberg A., and Harvey P.D. Neuropsychological impairments in schizophrenia: integration of performance-based and brain imaging findings. Psychol Bull 133 5 (2007) 833-858
253. Yoon J.H., Minzenberg M.J., Ursu S., et al. Association of dorsolateral prefrontal cortex dysfunction with disrupted coordinated brain activity in schizophrenia: relationship with impaired cognition, behavioral disorganization, and global function. Am J Psychiatry 165 8 (2008) 1006-1014
254. Maccabe J.H. Population-based cohort studies on premorbid cognitive function in schizophrenia. Epidemiol Rev 30 (2008) 77-83
255. Kuperberg G., and Heckers S. Schizophrenia and cognitive function. Curr Opin Neurobiol 10 2 (2000) 205-210
256. Lussier I., and Stip E. Memory and attention deficits in drug naïve patients with schizophrenia. Schizophr Res 48 1 (2001) 45-55
257. Goldberg T.E., Goldman R.S., Burdick K.E., et al. Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?. Arch Gen Psychiatry 64 10 (2007) 1115-1122
258. Saykin A.J., Shtasel D.L., Gur R.E., et al. Neuropsychological deficits in neuroleptic naïve patients with first-episode schizophrenia. Arch Gen Psychiatry 51 2 (1994) 124-131
259. Bilder R.M., Goldman R.S., Volavka J., et al. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry 159 6 (2002) 1018-1028
260. Holmen A., Juuhl-Langseth M., Thormodsen R., et al. Neuropsychological profile in early-onset schizophrenia-spectrum disorders: measured with the MATRICS battery. Schizophr Bull (2009) 17 [Epub ahead of print]
261. Woodberry K.A., Giuliano A.J., and Seidman L.J. Premorbid IQ in schizophrenia: a meta-analytic review. Am J Psychiatry 165 5 (2008) 579-587
262. Leeson V.C., Barnes T.R., Hutton S.B., et al. IQ as a predictor of functional outcome in schizophrenia: a longitudinal, four-year study of first-episode psychosis. Schizophr Res 107 1 (2009) 55-60
263. Ma X., Wang Q., Sham P.C., et al. Neurocognitive deficits in first-episode schizophrenic patients and their first-degree relatives. Am J Med Genet B Neuropsychiatr Genet 144 4 (2007) 407-416
264. Tan H.Y., Chen Q., Goldberg T.E., et al. Catechol-O-methyltransferase Val158Met modulation of prefrontal-parietal-striatal brain systems during arithmetic and temporal transformations in working memory. J Neurosci 27 49 (2007) 13393-13401
265. Tan H.Y., Chen Q., Sust S., et al. Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function. Proc Natl Acad Sci U S A 104 30 (2007) 12536-12541
266. Censits D.M., Ragland J.D., Gur R.C., et al. Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study. Schizophr Res 24 3 (1997) 289-298
267. Schuepbach D., Keshavan M.S., Kmiec J.A., et al. Negative symptom resolution and improvements in specific cognitive deficits after acute treatment in first-episode schizophrenia. Schizophr Res 53 3 (2002) 249-261
268. Snyder P.J., Jackson C.E., Piskulic D., et al. Spatial working memory and problem solving in schizophrenia: the effect of symptom stabilization with atypical antipsychotic medication. Psychiatry Res 160 3 (2008) 316-326
269. Hartman M., Steketee M.C., Silva S., et al. Working memory and schizophrenia: evidence for slowed encoding. Schizophr Res 59 2-3 (2003) 99-113
270. Honey G.D., Bullmore E.T., and Sharma T. De-coupling of cognitive performance and cerebral functional response during working memory in schizophrenia. Schizophr Res 53 1-2 (2002) 45-56
271. Okada A. Deficits of spatial working memory in chronic schizophrenia. Schizophr Res 53 1-2 (2002) 75-82
272. Tek C., Gold J., Blaxton T., et al. Visual perceptual and working memory impairments in schizophrenia. Arch Gen Psychiatry 59 2 (2002) 146-153
273. Spindler K.A., Sullivan E.V., Menon V., et al. Deficits in multiple systems of working memory in schizophrenia. Schizophr Res 27 1 (1997) 1-10
274. Zilles D., Burke S., Schneider-Axmann T., et al. Diagnosis-specific effect of familial loading on verbal working memory in schizophrenia. Eur Arch Psychiatry Clin Neurosci 259 6 (2009) 309-315
275. Pae C.U., Juh R., Yoo S.S., et al. Verbal working memory dysfunction in schizophrenia: an FMRI investigation. Int J Neurosci 118 10 (2008) 1467-1487
276. Potkin S.G., Turner J.A., Brown G.G., et al. Working memory and DLPFC inefficiency in schizophrenia: the FBIRN study. Schizophr Bull 35 1 (2009) 19-31
277. Driesen N.R., Leung H.C., Calhoun V.D., et al. Impairment of working memory maintenance and response in schizophrenia: functional magnetic resonance imaging evidence. Biol Psychiatry 64 12 (2008) 1026-1034
278. Forbes N.F., Carrick L.A., McIntosh A.M., et al. Working memory in schizophrenia: a meta-analysis. Psychol Med 39 6 (2009) 889-905
279. Zanello A., Curtis L., Badan Ba M., et al. Working memory impairments in first-episode psychosis and chronic schizophrenia. Psychiatry Res 165 1-2 (2009) 10-18
280. Kebir O., and Tabbane K. Working memory in schizophrenia: a review. Encephale 34 3 (2008) 289-298
281. Meda S.A., Bhattarai M., Morris N.A., et al. An fMRI study of working memory in first-degree unaffected relatives of schizophrenia patients. Schizophr Res 104 1-3 (2008) 85-95
282. Fuller R.L., Luck S.J., Braun E.L., et al. Impaired visual working memory consolidation in schizophrenia. Neuropsychology 23 1 (2009) 71-80
283. Calkins M.E., Gur R.C., Ragland J.D., et al. Face recognition memory deficits and visual object memory performance in patients with schizophrenia and their relatives. Am J Psychiatry 162 10 (2005) 1963-1966
284. Weiss A.P., Schacter D.L., Goff D.C., et al. Impaired hippocampal recruitment during normal modulation of memory performance in schizophrenia. Biol Psychiatry 53 1 (2003) 48-55
285. Snitz B.E., Macdonald III A.W., and Carter C.S. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophr Bull 32 1 (2006) 179-194
286. Skelley S.L., Goldberg T.E., Egan M.F., et al. Verbal and visual memory: characterizing the clinical and intermediate phenotype in schizophrenia. Schizophr Res 105 1-3 (2008) 78-85
287. Landro N.I., and Ueland T. Verbal memory and verbal fluency in adolescents with schizophrenia spectrum disorders. Psychiatry Clin Neurosci 62 6 (2008) 653-661
288. Manschreck T.C., Maher B.A., Candela S.F., et al. Impaired verbal memory is associated with impaired motor performance in schizophrenia: relationship to brain structure. Schizophr Res 43 1 (2000) 21-32
289. Elvevag B., Weinberger D.R., and Goldberg T.E. The phonological similarity effect in short-term memory serial recall in schizophrenia. Psychiatry Res 112 1 (2002) 77-81
290. Gabrovska V.S., Laws K.R., Sinclair J., et al. Visual object processing in schizophrenia: evidence for an associative agnosic deficit. Schizophr Res 59 2-3 (2003) 277-286
291. Perry W., Light G.A., Davis H., et al. Schizophrenia patients demonstrate a dissociation on declarative and non-declarative memory tests. Schizophr Res 46 2-3 (2000) 167-174
292. Ungvari G.S., Xiang Y.T., Tang W.K., et al. Prospective memory and its correlates and predictors in schizophrenia: an extension of previous findings. Arch Clin Neuropsychol 23 5 (2008) 613-622
293. Wang Y., Chan R.C., Hong X., et al. Prospective memory in schizophrenia: further clarification of nature of impairment. Schizophr Res 105 1-3 (2008) 114-124
294. Ranganath C., Minzenberg M.J., and Ragland J.D. The cognitive neuroscience of memory function and dysfunction in schizophrenia. Biol Psychiatry 64 1 (2008) 18-25
295. Kuperberg G.R., West W.C., Lakshmanan B.M., et al. Functional magnetic resonance imaging reveals neuroanatomical dissociations during semantic integration in schizophrenia. Biol Psychiatry 64 5 (2008) 407-418
296. Razafimandimby A., Maiza O., Herve P.Y., et al. Stability of functional language lateralization over time in schizophrenia patients. Schizophr Res 94 1-3 (2007) 197-206
297. Nicolson R., Lenane M., Singaracharlu S., et al. Premorbid speech and language impairments in childhood-onset schizophrenia: association with risk factors. Am J Psychiatry 157 5 (2000) 794-800
298. Jones P., Rodgers B., Murray R., et al. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 344 8934 (1994) 1398-1402
299. Done D.J., Crow T.J., Johnstone E.C., et al. Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ 309 6956 (1994) 699-703
300. Marini A., Spoletini I., Rubino I.A., et al. The language of schizophrenia: an analysis of micro and macrolinguistic abilities and their neuropsychological correlates. Schizophr Res 105 1-3 (2008) 144-155
301. Elvevag B., Weinstock D.M., Akil M., et al. A comparison of verbal fluency tasks in schizophrenic patients and normal controls. Schizophr Res 51 2-3 (2001) 119-126
302. Doughty O.J., Done D.J., Lawrence V.A., et al. Semantic memory impairment in schizophrenia-deficit in storage or access of knowledge?. Schizophr Res 105 1-3 (2008) 40-48
303. Li X., Branch C.A., Bertisch H.C., et al. An fMRI study of language processing in people at high genetic risk for schizophrenia. Schizophr Res 91 1-3 (2007) 62-72
304. Harris J.G., Minassian A., and Perry W. Stability of attention deficits in schizophrenia. Schizophr Res 91 1-3 (2007) 107-111
305. Liu S.K., Chiu C.H., Chang C.J., et al. Deficits in sustained attention in schizophrenia and affective disorders: stable versus state-dependent markers. Am J Psychiatry 159 6 (2002) 975-982
306. Birkett P., Sigmundsson T., Sharma T., et al. Reaction time and sustained attention in schizophrenia and its genetic predisposition. Schizophr Res 95 1-3 (2007) 76-85
307. Tsuang H.C., Lin S.H., Liu S.K., et al. More severe sustained attention deficits in nonpsychotic siblings of multiplex schizophrenia families than in those of simplex ones. Schizophr Res 87 1-3 (2006) 172-180
308. Luck S.J., and Gold J.M. The construct of attention in schizophrenia. Biol Psychiatry 64 1 (2008) 34-39
309. Fuller R.L., Luck S.J., Braun E.L., et al. Impaired control of visual attention in schizophrenia. J Abnorm Psychol 115 2 (2006) 266-275
310. Gur R.E., Turetsky B.I., Loughead J., et al. Visual attention circuitry in schizophrenia investigated with oddball event-related functional magnetic resonance imaging. Am J Psychiatry 164 3 (2007) 442-449
311. O'Grada C., Barry S., McGlade N., et al. Does the ability to sustain attention underlie symptom severity in schizophrenia?. Schizophr Res 107 2-3 (2009) 319-323
312. Kerns J.G., Nuechterlein K.H., Braver T.S., et al. Executive functioning component mechanisms and schizophrenia. Biol Psychiatry 64 1 (2008) 26-33
313. Rusch N., Spoletini I., Wilke M., et al. Prefrontal-thalamic-cerebellar gray matter networks and executive functioning in schizophrenia. Schizophr Res 93 1-3 (2007) 79-89
314. Szeszko P.R., Strous R.D., Goldman R.S., et al. Neuropsychological correlates of hippocampal volumes in patients experiencing a first episode of schizophrenia. Am J Psychiatry 159 2 (2002) 217-226
315. Mortimer A.M. Cognitive function in schizophrenia-do neuroleptics make a difference?. Pharmacol Biochem Behav 56 4 (1997) 789-795
316. Heinrichs R.W., and Zakzanis K.K. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12 3 (1998) 426-445
317. Cuesta M.J., Peralta V., and Zarzuela A. Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study. Schizophr Res 48 1 (2001) 17-28
318. Pallanti S., Quercioli L., and Pazzagli A. Effects of clozapine on awareness of illness and cognition in schizophrenia. Psychiatry Res 86 3 (1999) 239-249
319. Purdon S.E., Jones B.D., Stip E., et al. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia. Arch Gen Psychiatry 57 3 (2000) 249-258
320. Purdon S.E., Malla A., Labelle A., et al. Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol. J Psychiatry Neurosci 26 2 (2001) 137-149
321. Smith R.C., Infante M., Singh A., et al. The effects of olanzapine on neurocognitive functioning in medication-refractory schizophrenia. Int J Neuropsychopharmacol 4 3 (2001) 239-250
322. Velligan D.I., Newcomer J., Pultz J., et al. Does cognitive function improve with quetiapine in comparison to haloperidol?. Schizophr Res 53 3 (2002) 239-248
323. Velligan D.I., Prihoda T.J., Sui D., et al. The effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes in standard treatment settings. J Clin Psychiatry 64 5 (2003) 524-531
324. Woodward N.D., Purdon S.E., Meltzer H.Y., et al. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int J Neuropsychopharmacol 8 3 (2005) 457-472
325. Keefe R.S., Silva S.G., Perkins D.O., et al. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophr Bull 25 2 (1999) 201-222
326. Davidson M., Galderisi S., Weiser M., et al. Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). Am J Psychiatry 166 6 (2009) 675-682
327. Gallhofer B., Jaanson P., Mittoux A., et al. Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol. Pharmacopsychiatry 40 6 (2007) 275-286
328. Houthoofd S.A., Morrens M., and Sabbe B.G. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder. Clin Ther 30 9 (2008) 1565-1589
329. Good K.P., Kiss I., Buiteman C., et al. Improvement in cognitive functioning in patients with first-episode psychosis during treatment with quetiapine: an interim analysis. Br J Psychiatry Suppl 43 (2002) s45-s49
330. Harvey P.D., Sacchetti E., Galluzzo A., et al. A randomized double-blind comparison of ziprasidone vs. clozapine for cognition in patients with schizophrenia selected for resistance or intolerance to previous treatment. Schizophr Res 105 1-3 (2008) 138-143
331. Mohamed S., Paulsen J.S., O'Leary D., et al. Generalized cognitive deficits in schizophrenia: a study of first-episode patients. Arch Gen Psychiatry 56 8 (1999) 749-754
332. Galletly C. Recent advances in treating cognitive impairment in schizophrenia. Psychopharmacology (Berl) 202 1-3 (2009) 259-273
333. Remillard S., Pourcher E., and Cohen H. Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia. J Int Neuropsychol Soc 14 1 (2008) 110-118
334. Akdede B.B., Anil Yagcioglu A.E., Alptekin K., et al. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition. J Clin Psychiatry 67 12 (2006) 1912-1919
335. Elie D., Poirier M., Chianetta J., et al. Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder. J Psychopharmacol (2009) 22 [Epub ahead of print]
336. Buchanan R.W., Freedman R., Javitt D.C., et al. Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia. Schizophr Bull 33 5 (2007) 1120-1130
337. Barr R.S., Culhane M.A., Jubelt L.E., et al. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology 33 3 (2008) 480-490
338. Harvey P.D., and Cornblatt B.A. Pharmacological treatment of cognition in schizophrenia: an idea whose method has come. Am J Psychiatry 165 2 (2008) 163-165
339. Nuechterlein K.H., Green M.F., Kern R.S., et al. The MATRICS consensus cognitive battery, part 1: test selection, reliability, and validity. Am J Psychiatry 165 2 (2008) 203-213
340. Sergi M.J., Rassovsky Y., Widmark C., et al. Social cognition in schizophrenia: relationships with neurocognition and negative symptoms. Schizophr Res 90 1-3 (2007) 316-324
341. Sergi M.J., Rassovsky Y., Nuechterlein K.H., et al. Social perception as a mediator of the influence of early visual processing on functional status in schizophrenia. Am J Psychiatry 163 3 (2006) 448-454